VALBIOTIS (EPA:ALVAL) | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
VALBIOTIS

BRIEF

published on 11/05/2024 at 18:05, 15 days 18 hours ago

Valbiotis approves share buyback program at General Meeting

Share Buyback Valbiotis General Assembly Food Supplements Resolutions Voted
BRIEF

published on 11/05/2024 at 18:05, 15 days 18 hours ago

Valbiotis approuve le programme de rachat d'actions lors de l'Assemblée Générale

Rachat D'actions Assemblée Générale Valbiotis Compléments Alimentaires Résolutions Votées
PRESS RELEASE

published on 11/05/2024 at 18:00, 15 days 18 hours ago

VALBIOTIS SA: Compte-rendu de l’Assemblée Générale Ordinaire du 5 novembre 2024
Valbiotis SA a tenu son Assemblée Générale Ordinaire le 5 novembre 2024. Les actionnaires votent à l'unanimité pour un programme de rachat d'actions. Valbiotis, spécialisé en nutrition santé, vise la lutte contre les maladies cardiovasculaires

Assemblée Générale Valbiotis Maladies Cardiovasculaires Résultats Des Votes Nutrition Santé
BRIEF

published on 10/29/2024 at 17:45, 22 days 19 hours ago

Valbiotis publie ses résultats financiers et ses développements stratégiques pour le premier semestre 2024

Valbiotis Lancement De Produit États Financiers Intermédiaires Feuille De Route Stratégique Résultats Scientifiques
BRIEF

published on 10/29/2024 at 17:45, 22 days 19 hours ago

Valbiotis Reports H1 2024 Financial Results and Strategic Developments

Valbiotis Product Launch Strategic Roadmap Interim Financials Scientific Results
PRESS RELEASE

published on 10/29/2024 at 17:40, 22 days 19 hours ago

VALBIOTIS publishes its interim financial statements
Valbiotis publishes interim financial statements for H1 2024 showing a cash position of €18.5M and confirming its commercial roadmap. Key events review the successful launch of Valbiotis@PRO Cholesterol

Cash Position Valbiotis Product Launch Interim Financial Statements Commercial Roadmap
PRESS RELEASE

published on 10/29/2024 at 17:40, 22 days 19 hours ago

VALBIOTIS publie ses résultats semestriels
Valbiotis publie ses résultats semestriels avec une trésorerie de plus de 18,5 M€ et confirme sa feuille de route commerciale. Lancement réussi de Valbiotis@PRO Cholestérol en France et avancées significatives dans les études cliniques des produits TOTUM. Nouveau DAF nommé pour accompagner le pivot stratégique de l'entreprise

Résultats Semestriels Valbiotis Trésorerie Études Cliniques Feuille De Route Commerciale
BRIEF

published on 10/17/2024 at 17:45, 1 month 3 days ago

Valbiotis : Assemblée Générale Ordinaire du 5 novembre 2024

Actionnaires Contrat De Liquidité Assemblée Générale Valbiotis Compléments Alimentaires
BRIEF

published on 10/17/2024 at 17:45, 1 month 3 days ago

Valbiotis: Ordinary General Meeting of November 5, 2024

Shareholders Liquidity Contract Valbiotis General Assembly Food Supplements
PRESS RELEASE

published on 10/17/2024 at 17:40, 1 month 3 days ago

VALBIOTIS : Assemblée Générale Ordinaire du 5 novembre 2024
Valbiotis annonce son Assemblée Générale Ordinaire du 5 novembre 2024 pour permettre aux actionnaires de se prononcer sur diverses résolutions. Consultation des documents préparatoires disponible en ligne

Rachat D'actions Actionnaires Assemblée Générale Valbiotis Prévention Troubles Métaboliques

Accesswire

Published on 11/21/2024 at 12:00, 47 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 47 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 17 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 44 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 47 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 12 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 32 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 41 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 47 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 17 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 49 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 49 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 49 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 40 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 27 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE